atomoxetine hydrochloride has been researched along with Pregnancy in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Cesta, CE; Cohen, JM; Furu, K; Karlstad, Ø; Reutfors, J; Srinivas, C | 1 |
| Bateman, BT; Bröms, G; Einarsdóttir, K; Engeland, A; Furu, K; Gissler, M; Hernandez-Diaz, S; Huybrechts, KF; Karlsson, P; Kieler, H; Klungsøyr, K; Kristiansen, EB; Lahesmaa-Korpinen, AM; Mogun, H; Nørgaard, M; Reutfors, J; Sørensen, HT; Zoega, H | 1 |
| Chen, M; He, T; Wen, Y | 1 |
| Bérard, A; Boukhris, T; Lemelin, M; Sheehy, O; Zhao, JP | 1 |
| Alkam, T; Aoyama, Y; Hiramatsu, M; Kihara, D; Kim, HC; Kimura, N; Mamiya, T; Nabeshima, T; Tsunoda, Y; Yoshida, A | 1 |
| Bateman, BT; Cohen, JM; Desai, RJ; Gray, KJ; Hernández-Díaz, S; Huybrechts, KF; Mogun, H; Park, Y; Patorno, E | 1 |
| Akita, H; Ishibashi, H; Ogata, M | 1 |
| Aagaard, L; Hansen, EH; Warrer, P | 1 |
| Guerrero-Álvarez, Á; Juárez, J | 1 |
| Ago, Y; Hara, Y; Hasebe, S; Hashimoto, H; Katashiba, K; Matsuda, T; Onaka, Y; Takano, E; Takuma, K; Taruta, A | 1 |
| Belousova, MB; Morozova, EA | 1 |
| Findling, RL; Rowles, BM | 1 |
| Fernández-Jaén, A; Martín Fernández-Mayoralas, D | 1 |
| Drago, F; Mazzola, C; Micale, V; Salomone, S; Tamburella, A | 1 |
| Terry, AV; Wilson, CA | 1 |
| Biederman, J; Faraone, SV; Spencer, TJ; Wilens, TE | 1 |
| Alessi, NE; Spalding, S | 1 |
| Christman, AK; Fermo, JD; Markowitz, JS | 1 |
| Garcia-Bournissen, F; Humphreys, C; Ito, S; Koren, G | 1 |
5 review(s) available for atomoxetine hydrochloride and Pregnancy
| Article | Year |
|---|---|
Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
Topics: Adolescent; Amphetamines; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Clinical Trials as Topic; Clonidine; Comorbidity; Developmental Disabilities; Drug Therapy, Combination; Female; Fetal Alcohol Spectrum Disorders; Humans; Intellectual Disability; Male; Methylphenidate; Pregnancy; Propylamines; Psychotropic Drugs | 2010 |
[Alcoholic foetopathy: an update].
Topics: Adrenergic Uptake Inhibitors; Alcoholism; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Cognition Disorders; Diagnosis, Differential; Female; Fetal Alcohol Spectrum Disorders; Humans; Methylphenidate; Nervous System Malformations; Pregnancy; Propylamines; Randomized Controlled Trials as Topic | 2011 |
Overview and neurobiology of attention-deficit/hyperactivity disorder.
Topics: Adult; Age Factors; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Child; Diagnosis, Differential; Diseases in Twins; Female; Global Health; Humans; Magnetic Resonance Imaging; Prefrontal Cortex; Pregnancy; Prevalence; Propylamines; Risk Factors | 2002 |
Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder.
Topics: Adolescent; Adult; Animals; Area Under Curve; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Female; Half-Life; Humans; Intestinal Absorption; Male; Pregnancy; Propylamines; Randomized Controlled Trials as Topic; Severity of Illness Index; Tissue Distribution; Treatment Outcome | 2004 |
Exposure to attention deficit hyperactivity disorder medications during pregnancy.
Topics: Abnormalities, Drug-Induced; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Congenital Abnormalities; Decision Making; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant, Newborn; Methylphenidate; Pregnancy; Pregnancy Complications; Propylamines; Risk Assessment | 2007 |
14 other study(ies) available for atomoxetine hydrochloride and Pregnancy
| Article | Year |
|---|---|
Prevalence trends and individual patterns of ADHD medication use in pregnancy in Norway and Sweden, 2010-2019.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Female; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Norway; Pregnancy; Prevalence; Sweden | 2023 |
Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations: A Multinational Study.
Topics: Abnormalities, Drug-Induced; Atomoxetine Hydrochloride; Cohort Studies; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Pregnancy; Pregnancy Trimester, First; Prevalence | 2023 |
[Clinical and genetic analysis of a child with maternal uniparental disomy of chromosome 20].
Topics: Adult; Atomoxetine Hydrochloride; Child; Chromosomes, Human, Pair 20; DNA Copy Number Variations; Dwarfism; Female; Growth Disorders; Humans; Infant; Insulins; Intercellular Signaling Peptides and Proteins; Language Development Disorders; Male; Pregnancy; Retrospective Studies; Uniparental Disomy | 2023 |
Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cohort Studies; Drug Utilization; Female; Humans; Maternal-Fetal Exchange; Pregnancy; Prevalence; Quebec; Young Adult | 2021 |
Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cognition Disorders; Dopamine; Female; Male; Mice; Mice, Inbred C57BL; Nicotine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects | 2017 |
Placental Complications Associated With Psychostimulant Use in Pregnancy.
Topics: Abruptio Placentae; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cohort Studies; Female; Fetal Growth Retardation; Humans; Methylphenidate; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimesters; Premature Birth; Risk Assessment; Statistics as Topic | 2017 |
Behavioral responses to anxiogenic tasks in young adult rats with neonatal dopamine depletion.
Topics: Adrenergic Uptake Inhibitors; Animals; Animals, Newborn; Anxiety; Atomoxetine Hydrochloride; Behavior, Animal; Dopamine; Dopamine Uptake Inhibitors; Exploratory Behavior; Female; Lighting; Maze Learning; Methamphetamine; Motor Activity; Nerve Net; Oxidopamine; Pregnancy; Rats; Rats, Wistar | 2019 |
Comparison of pregnancy and lactation labeling for attention-deficit hyperactivity disorder drugs marketed in Australia, the USA, Denmark, and the UK.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Australia; Benzhydryl Compounds; Central Nervous System Stimulants; Contraindications; Data Collection; Denmark; Drug Labeling; Female; Humans; Lactation; Methylphenidate; Modafinil; Pregnancy; Propylamines; United Kingdom; United States | 2014 |
Effects of methylphenidate and atomoxetine on impulsivity and motor activity in preadolescent rats prenatally-treated with alcohol.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Central Nervous System Depressants; Central Nervous System Stimulants; Delay Discounting; Disease Models, Animal; Ethanol; Female; Fetal Alcohol Spectrum Disorders; Impulsive Behavior; Male; Methylphenidate; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Psychotropic Drugs; Rats, Wistar | 2015 |
Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism.
Topics: Animals; Atomoxetine Hydrochloride; Autistic Disorder; Behavior, Animal; Dendritic Spines; Disease Models, Animal; Dopamine; Female; Humans; Interpersonal Relations; Male; Methylphenidate; Mice; Mice, Inbred ICR; Norepinephrine; Prefrontal Cortex; Pregnancy; Receptors, Dopamine D1; Recognition, Psychology; Valproic Acid | 2016 |
[Attention deficit hyperactivity syndrome: evolution, clinical presentations, treatment].
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Female; Humans; Male; Pregnancy; Pregnancy Complications; Propylamines | 2009 |
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats.
Topics: Aging; Animals; Animals, Newborn; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Male; Memory; Motor Activity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Pregnancy; Prenatal Exposure Delayed Effects; Propylamines; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Trimethyltin Compounds | 2012 |
Variable maternal stress in rats alters locomotor activity, social behavior, and recognition memory in the adult offspring.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Antipsychotic Agents; Atomoxetine Hydrochloride; Behavior, Animal; Benzylidene Compounds; Disease Models, Animal; Female; Humans; Male; Maze Learning; Mental Disorders; Motor Activity; Nicotinic Agonists; Pregnancy; Prenatal Exposure Delayed Effects; Propylamines; Pyridines; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Risperidone; Social Behavior; Stress, Physiological | 2013 |
Atomoxetine and pregnancy.
Topics: Adolescent; Adrenergic Antagonists; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Female; Humans; Patient Selection; Pregnancy; Propylamines | 2003 |